Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.2%

1 terminated out of 31 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

13%

4 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results91% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (5)
P 1 (1)
P 2 (5)
P 3 (4)

Trial Status

Completed10
Unknown8
Recruiting7
Not Yet Recruiting2
Active Not Recruiting1
Terminated1

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT06393712Phase 2RecruitingPrimary

A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy

NCT04204642RecruitingPrimary

SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)

NCT06714097Not ApplicableRecruiting

Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)

NCT06960538CompletedPrimary

Enpowering Progression Risk of Cerebral Amyloid Angiopathy

NCT06421532Phase 2Enrolling By InvitationPrimary

Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy

NCT05709314Phase 2RecruitingPrimary

A Study of AMDX-2011P in Participants With CAA

NCT03464344Not ApplicableCompletedPrimary

Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.

NCT07250035Phase 3Not Yet RecruitingPrimary

Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy

NCT05565144Completed

Brain Hemorrhage and Functional Outcome in Stroke Patients With CAA Features on Pre-thrombolysis MRI Treated With Intravenous Thrombolysis (Thrombolysis in CAA) ( Thromb in CAA )

NCT05486897CompletedPrimary

Periventricular White Matter Hyperintensities in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy

NCT05394636CompletedPrimary

Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy

NCT06128824Active Not RecruitingPrimary

High Frequency Imaging in Cerebral Amyloid Angiopathy

NCT07026994Phase 2RecruitingPrimary

Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage

NCT06933212RecruitingPrimary

Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.

NCT06888882Not Yet Recruiting

Dilated Perivascular Spaces in the Dentate Nucleus on MRI in Patients with Hypertensive Angiopathy or Cerebral Amyloid Angiopathy

NCT05499169TerminatedPrimary

Coach Pilot Study: Assessing Cognitive Function and Related Small Vessel Disease Markers After Intracerebral Hemorrhage

NCT05734378RecruitingPrimary

Prognosis of Cerebral Small Vessel Disease

NCT05680389Phase 1UnknownPrimary

Antibiotics Against Amyloid Angiopathy

NCT05207475Not ApplicableUnknownPrimary

Safety and Efficacy of Remote Ischemic Conditioning on Cerebral Amyloid Angiopathy. (RIC-CAA)

NCT05082194CompletedPrimary

Balance Eyesight and Muscle Tension in the Cervical Spine in Cerebral Amyloid Angiopathy

Scroll to load more

Research Network

Activity Timeline